DSM reported +10% higher sales of continued operations to €7,722m driven by some higher volumes (+3%; mainly Nutrition) and favourable FX developments (+8%). EBITDA slightly weakened by 3% to €956m, suffering from Nutrition’s lower contribution and some higher one-offs (e.g. the efficiency improvement programmes). Net profit attributable to shareholders came in at €88m after €145m. Operating CF suffered from higher outflows for Other (€-387m after €-202m) d
17 Feb 2016
Just higher volumes make fun of the organic business
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Just higher volumes make fun of the organic business
- Published:
17 Feb 2016 -
Author:
Martin Schnee - Pages:
DSM reported +10% higher sales of continued operations to €7,722m driven by some higher volumes (+3%; mainly Nutrition) and favourable FX developments (+8%). EBITDA slightly weakened by 3% to €956m, suffering from Nutrition’s lower contribution and some higher one-offs (e.g. the efficiency improvement programmes). Net profit attributable to shareholders came in at €88m after €145m. Operating CF suffered from higher outflows for Other (€-387m after €-202m) d